IFUL Insightful Corp (MM)

Insightful Corporation (Nasdaq:IFUL), a leading provider of software solutions for analysis of numeric and text data, announced today that Dr. Michael O'Connell, director of Life Science Solutions for Insightful Corporation, will participate in the Drug Information Association (DIA) webinar on "Best Practices in Graphical and Tabular Safety Data Analysis and Reporting" on November 30, 2005, at 12:00 p.m. EST. This webinar is designed for clinical data analysis professionals involved in the areas of clinical study reporting, safety data analysis, clinical data browsing, pharmacovigilance, pharmacoepidemiology, regulatory affairs, statistics, biostatistics, modeling, quality assurance, medical product safety assessment, and labeling. The webinar will include a review of statistical analysis, reporting and data mining of clinical/safety data by way of several case studies involving clinical trial and FDA AERS observational database. Other participants include speakers from a leading pharmaceutical company and the FDA. "The assessment and monitoring of drug safety is an important current challenge in the pharmaceutical industry," said Dr. O'Connell. "Careful statistical analysis and graphical reporting of adverse events in clinical studies, and from observational databases, is the key to proactive vigilance of drug safety. The need for sophisticated analytics is now widely recognized, and Insightful is engaged in providing software solutions to the space." Dr. O'Connell has been working in the medical device, diagnostics, pharmaceutical, and biotech arena for the past 15 years. He has recently concentrated his efforts in two areas: statistical analysis of safety data and statistical analysis of microarray data. In both of these areas, O'Connell is involved in the design and development of tools for analysis and reporting of clinical and discovery data from S-PLUS. O'Connell was recently named one of the most "100 Most Inspiring People in the Life-Sciences Industry" by the readers of PharmaVOICE magazine. Attendees of the webinar will learn to: -- Recognize current statistical methods for analysis of safety data in clinical trials -- Describe current statistical methods for analysis of adverse event reports and signal detection in post-marketing databases (e.g. FDA AERS) -- Explain methods for graphical analysis, reporting and review of safety data in clinical trials -- Explain methods for graphical analysis and reporting of safety data in post-marketing databases To register for this event, please visit https://online-e-vents.com/dia05238. ABOUT INSIGHTFUL Insightful Corporation (Nasdaq:IFUL) provides enterprises with scalable data analysis solutions that drive better decisions faster by revealing patterns, trends and relationships. The company is a leading supplier of software and services for statistical data analysis, data mining and knowledge access enabling clients to gain intelligence from numeric and text data. Insightful products include S-PLUS(R), Insightful Miner(TM), S-PLUS(R) Server and InFact(R). Insightful consulting services provide specialized expertise and proven processes for the design, development and deployment of customized solutions. The company has been delivering industry-leading, high-ROI solutions to thousands of companies in financial services, life sciences, biotechnology, telecommunications, and manufacturing, plus government and research institutions. Headquartered in Seattle, Insightful has offices in North Carolina, France, Switzerland, and the United Kingdom, with distributors around the world. For more information, visit www.insightful.com, email info@insightful.com or call 800-569-0123.